TotalMarketCap

Bristol Myers Squibb

BMYNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$121.725 B

$59.59 +1.33%

Close of 7 Oct 2026

As of 7 Oct 2026, Bristol Myers Squibb (BMY) has a market capitalization of $121.7B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$48.2B

#87 by revenue

Earnings

$7.05B

#70 by earnings

Shares outstanding

2,042,714,656

Latest filing cover page

P/E ratio

17.3

Cap ÷ net income

Other share classes

Bristol Myers Squibb lists more than one class of stock. Company figures above cover all classes combined.

CELG-RI

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #9PfizerPFE$156.7B
  2. #10Vertex PharmaceuticalsVRTX$127.3B
  3. #11Bristol Myers SquibbBMY$121.7B
  4. #12SanofiSNY$96.5B
  5. #13GSKGSK$94.3B

What if Bristol Myers Squibb were worth as much as…

Open the what-if tool →

Gold $28.8T

$14,093.71

Per share 237× higher

Bitcoin $1.67T

$817.66

Per share 13.7× higher

Nvidia $5.77T

$2,822.56

Per share 47.4× higher

Or at a round number

$200.0B$500.0B$1.00T$2.00T

Where these numbers come from

Share counts and financials for Bristol Myers Squibb are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.